South China Morning Post with the sobering news from a study at the epicentre of China’s coronavirus outbreak earlier this year.
- study focuses on whether hospital workers in Wuhan who were directly exposed to infected patients at the early stage of the outbreak had developed antibodies
- “People are unlikely to produce long-lasting protective antibodies against this virus,” the researchers concluded in a non-peer-reviewed paper posted on preprint website medRxiv.org
Runs counter to the implied talking points from Pres. Trump
- No evidence that any drug reducing mortality of patients that have Covid 19.
- experts advise the continuation of all forms of the solid parity trial including hydroxychloroquine srm
- No reason to modify clinical trial of hydroxychloroquine in Covid 19
- the air quarters only to be considered when it is a safe
- no one is safe until we all are safe from the virus
- urges people to not move outdoor gatherings indoors if it rains
- there could be a 2nd wave of virus across the world
- the UK chief science advisor adds have to tread cautiously in lifting UK lockdown
- facts show that virus has disappeared
- virus reconstruction is the time for long-delayed reforms
- government working to speed up 8 payments
- deaths reach 11,880 and cases reach 162,068
- he urges protesters to keep distance and wear masks during George Floyd demonstrations.
- At least 6 demonstrations today in New Jersey
Novavax says it has begun enrolling participants in first human study of its coronavirus vaccine
- The company says it’ll test vaccine safety, immune responses in about 130 healthy adults in Australia
- expects initial results in July
- to expand study to US if promising
The big problem I see here is how to begin the pump and dump scheme if NASDAQ is closed for the holiday?
Novavax is a US vaccine development company.
According to a poll by Reuters/Ipsos, a quarter of Americans have little or no interest in taking a coronavirus vaccine
Wuhan was the epicentre of the coronavirus pandemic in China. Its a big city, with a population of around 11m people.
- Wuhan will become a “wildlife sanctuary”
- virtually all hunting of wild animals to be banned (exception for “scientific research, population regulation, monitoring of epidemic diseases and other special circumstances”).
- also introduced controls on the breeding of all wild animals
- prohibiting any to be reared for food
• 24 Hours at the Epicenter of the Coronavirus Pandemic: Doctors, nurses, a congressman, workers in deserted museums and theatres, men on early release from Rikers, and the newly unemployed strained to keep New York City, and themselves, going. (New Yorker)
• What if immunity to covid-19 doesn’t last? (MIT Technology Review)
• ‘Frostbite’ toes and other peculiar rashes may be signs of hidden coronavirus infection, especially in the young (Washington Post)
• We have to wake up: factory farms are breeding grounds for pandemics (The Guardian)
Aid and assistance:
• COVID Tests Are Free, Except When They’re Not (Kaiser Health News)
• Useful table of extended state tax filing deadlines (Tax Foundation)
• Figuring Out Your Personal Finances Together (Wall Street Journal)
Staying Sane WFH:
• Signs You May Be Burning Out—and What to Do About It (Businessweek)
• “It Is Harrowing. It Is Daunting. It Is Overwhelming”: The Mental Toll of Coronavirus Is Crushing Medical Workers (Vanity Fair)
• Which epidemiologist do you believe? (UnHerd)
• Yuval Noah Harari: ‘Will coronavirus change our attitudes to death? Quite the opposite’ (The Guardian)
Vaccine & Treatment Updates:
• In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead (New York Times)
• Some Countries Are Squashing the Coronavirus Curve. Vietnam Is One. (Wall Street Journal)
• Three potential coronavirus vaccines moving ahead in tests (Los Angeles Times)
• When will we get the Covid-19 vaccine? (UnHerd) see also How Long Will a Vaccine Really Take? (New York Times)
• UCSF team has discovered drugs that block coronavirus, paving way for ‘a better drug sooner’ (San Francisco Chronicle)
• The Secret Group of Scientists and Billionaires Pushing a Manhattan Project for Covid-19 (Wall Street Journal)
Resolving the Crisis:
• Dogs are being trained to sniff out coronavirus cases (Washington Post)
• Could contact tracing bring the US out of lockdown? (Vox)
• LA Becomes The First Major City In The US To Offer Free Testing To Every Resident, Even Those With No Symptoms (LAist)
• Why America’s coronavirus testing problem is still so difficult to solve (Vox)
• No Testing, No Treatment, No Herd Immunity, No Easy Way Out (The Atlantic)
• Poop may tell us when the coronavirus lockdown will end (LA Times)
• We Cannot “Reopen” America: The source of the economic shock is not government orders. It’s the pandemic. (The Bulwark)
• Reopening Plans Across U.S. Are Creating Confusing Patchwork (New York Times)
• What will cities look like once the lockdown lifts? (King’s College London)
• Five Ways the U.S. Military Will Change After the Pandemic (War on the Rocks)
• Will Travel Change After Coronavirus? Here’s What Experts Have to Say (Travel & Leisure)
• The Office You Left Is Not Going to Be the Office You Return To (Bloomberg)
• One Rich N.Y. Hospital Got Warren Buffett’s Help. This One Got Duct Tape. (New York Times)
• Covid-19’s future: small outbreaks, monster wave, or ongoing crisis (Stat)
• What the Coronavirus Crisis Reveals About American Medicine (New Yorker)
• The Immunity of the Tech Giants: When the pandemic is over, we most certainly should fear the industry more than ever (New York Times)
US President Trump expressing optimism that coronavirus new case growth has peaked
- Says will be announcing new guidelines on reopening the US economy on Thursday *US time)
- three are already already being tested in human trials
- Hong Kong-listed CanSino Biologics
- Beijing Institute of Biotechnology
- US’ Moderna and Inovio Pharmaceuticals
- Pfizer and Sanofi also
The flu drug Avigan will be made available at no cost to countries that ask for it to treat the novel coronavirus, the Japanese government announced Friday.
Chief Cabinet Secretary Yoshihide Suga told a news conference that about 30 countries have sought Avigan through diplomatic channels. “We are making arrangements to provide it for free,” he said.
Doing so will help expand clinical research into the drug, Suga said. At 2,617 cases as of Friday, Japan has relatively few of the more than 1 million infections worldwide, making broad clinical trials difficult.
Indonesia ordered 2 million doses of Avigan on March 20, and the country plans to begin clinical testing once the shipment arrives. The country has seen coronavirus cases there surge to 1,986, after going weeks without confirming infections in the early stages of the epidemic. Indonesia now has 181 deaths, placing it higher than South Korea, and second only to China in Asia.
Japan has also received a request from Turkey. Turkish Health Minister Fahrettin Koca met with Akio Miyajima, the Japanese ambassador to Ankara, last month and inquired about acquiring Avigan, diplomatic sources told the Nikkei Asian Review. Continue reading »